Rising Civil Unrest Fuels Demand for Crowd Control Tech: Military Contractors Positioned for Growth

The U.S. has entered an era of heightened domestic instability, with civil unrest, border tensions, and political polarization driving unprecedented federal military deployment. As policymakers grapple with balancing public safety and civil liberties, demand for crowd control and security equipment is surging. For investors, this presents a compelling opportunity in military contractors specializing in non-lethal weapons, surveillance technology, and defensive systems.

A New Era of Federal Military Involvement

Recent U.S. policies, such as the 2025 deployment of National Guard and Marine forces to Los Angeles amid immigration protests, underscore a shift toward federal intervention in domestic unrest. Legal authorities like 10 U.S.C. § 杧2406—permitting military support for federal property protection—have expanded the Pentagon's role in domestic policing. This trend is likely to persist, given bipartisan concerns about civil disorder and evolving threats like domestic extremism.

The Department of Defense's push for “intermediate force capabilities” (IFCs), including non-lethal technologies and advanced surveillance systems, further signals long-term demand. Analysts estimate the global non-lethal weapons market will grow at a 6% CAGR through 2030, driven by U.S. and international procurement.

Key Companies and Investment Opportunities

Axon Enterprise (AXON): Leading the Non-Lethal Revolution

Axon dominates the market for non-lethal weapons, particularly its Taser devices and body camera systems. Since 2020, the company has secured over $61 million in contracts with U.S. Immigration and Customs Enforcement (ICE) and Customs and Border Protection (CBP), including a $17.9 million deal in 2020 for its Model X2 Taser.

Axon's stock has outperformed the broader market, rising 40% since early 2023 amid growing demand for its Evidence.com cloud platform, which integrates body camera footage with AI-driven analysis for law enforcement. The company's ties to federal agencies—ex-ICE officials now hold key roles—bolster its pipeline of contracts.

Cadre Holdings (DTRM): Tear Gas and the Global Market

Cadre's Safariland subsidiary is the U.S.'s largest producer of tear gas and riot control gear. Despite announcing plans to divest its Defense Technology unit in 2020, Safariland's sales to federal agencies have surged, with CBP spending over $700,000 on tear gas canisters in recent years. International demand—particularly from Israel and Southeast Asia—has driven 56% sales growth in 2021.

However, ethical concerns linger. Safariland's products have been linked to human rights abuses, prompting shareholder activism and regulatory scrutiny. While this poses reputational risks, demand for crowd control tools in volatile regions remains robust.

Raytheon Technologies (RTX): Advancing Directed Energy

Raytheon is pioneering cutting-edge non-lethal systems like directed-energy weapons (DEW), which use lasers or microwaves to disorient or incapacitate targets without physical contact. Though still in developmental phases, these technologies are critical to the Pentagon's IFC strategy.

Raytheon's broader defense portfolio, including surveillance drones and cybersecurity tools, provides diversification. Its stock has climbed steadily since 2021, reflecting investor confidence in its R&D pipeline and government contracts.

Risks and Regulatory Challenges

Investors must weigh risks, including legislative pushback on militarized policing and potential oversupply of non-lethal weapons. Congressional hearings on tear gas safety and bipartisan bills to restrict federal military deployment could limit demand. Additionally, public backlash over misuse—such as Taser-related deaths—may pressure companies to adopt stricter safeguards.

Conclusion: A Strategic Investment Play

The confluence of federal military deployment policies, rising civil unrest, and technological innovation creates a multi-year tailwind for crowd control and security equipment manufacturers. Axon and Cadre Holdings are best positioned to capitalize on near-term demand, while Raytheon's advanced systems offer long-term growth potential.

Investors should prioritize companies with diversified product lines, strong federal contracts, and ethical safeguards. Axon's 2024 revenue guidance of $1.2 billion—up 15% from 2023—supports a buy rating, while Cadre's valuation at 12x forward earnings reflects its risk-reward balance. For aggressive investors, Raytheon's R&D bets on DEW could yield outsized returns as the Pentagon scales up IFC programs.

In this era of instability, military contractors are not just profiting from chaos—they're shaping the tools that define how societies manage it.